Stay updated with breaking news from Update From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to Dr. Quigley, who addresses the importance of identifying and reducing residual inflammatory risk.
Safe, efficient, and effective treatment for both paroxysmal and persistent atrial fibrillation
Safe, efficient, and effective treatment for both paroxysmal and persistent atrial fibrillation DUBLIN, Dec. 13, 2023 /PRNewswire/ -- Medtronic plc , a global leader in healthcare technology, today...
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA)...
VANCOUVER, British Columbia, Dec. 02, 2023 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced it will provide updates on its neurology programs at the...